EE355 The Budgetary Consequences of Increasing Utilization of Dronedarone Relative to Other Antiarrythmic Drugs to a Hypothetical U.S. Payer
Abstract
Authors
J Ken-Opurum P Vadagam L Faith SSS Srinivas S Park S Charland A Revel